Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting

被引:19
作者
Buettner, Ralf [1 ]
Morales, Corey [1 ]
Caserta, Enrico [1 ]
Troadec, Estelle [1 ]
Gunes, Emine G. [1 ]
Viola, Domenico [1 ]
Khalife, Jihane [1 ]
Li, Hongzhi [2 ]
Keats, Jonathan J. [3 ]
Christofferson, Austin [3 ]
Wu, Xiwei [4 ]
Synold, Timothy W. [5 ]
Palmer, Joycelynne [2 ]
Sanchez, James F. [1 ]
Pozhitkov, Alexander [2 ]
Vaidehi, Nagarajan [2 ]
Marcucci, Guido [6 ]
Krishnan, Amrita [1 ]
Rosenzweig, Michael A. [1 ]
Pichiorri, Flavia [1 ]
Rosen, Steven T. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Hematol Malignancies & Stem Cell Transplantat Ins, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Duarte, CA USA
[3] Translat Genom Res Inst, Integrated Canc Genom, Phoenix, AZ USA
[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Integrat Genom Core, Duarte, CA USA
[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Gehr Family Ctr Leukemia Res, Hematol Malignancies & Stem Cell Transplantat Ins, Duarte, CA USA
基金
美国国家卫生研究院;
关键词
MULTIPLE-MYELOMA; KINASE INHIBITOR; IDENTIFICATION; ACTIVATION; PROMOTES; DRUG;
D O I
10.1182/bloodadvances.2018027227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1027 / 1032
页数:6
相关论文
共 25 条
  • [11] A murine model of myeloma that allows genetic manipulation of the host microenvironment
    Fowler, Jessica A.
    Mundy, Gregory R.
    Lwin, Seint T.
    Lynch, Conor C.
    Edwards, Claire M.
    [J]. DISEASE MODELS & MECHANISMS, 2009, 2 (11-12) : 604 - 611
  • [12] Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
    Hail, Numsen, Jr.
    Chen, Ping
    Bushman, Lane R.
    [J]. NEOPLASIA, 2010, 12 (06): : 464 - 475
  • [13] Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases
    Herrmann, ML
    Schleyerbach, R
    Kirschbaum, BJ
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 273 - 289
  • [14] Addiction to c-MYC in multiple myeloma
    Holien, Toril
    Vatsveen, Thea Kristin
    Hella, Hanne
    Waage, Anders
    Sundan, Anders
    [J]. BLOOD, 2012, 120 (12) : 2450 - 2453
  • [15] Multiple myeloma epidemiology and survival: A unique malignancy
    Kazandjian, Dickran
    [J]. SEMINARS IN ONCOLOGY, 2016, 43 (06) : 676 - 681
  • [16] Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
    Kroenke, Jan
    Udeshi, Namrata D.
    Narla, Anupama
    Grauman, Peter
    Hurst, Slater N.
    McConkey, Marie
    Svinkina, Tanya
    Heckl, Dirk
    Comer, Eamon
    Li, Xiaoyu
    Ciarlo, Christie
    Hartman, Emily
    Munshi, Nikhil
    Schenone, Monica
    Schreiber, Stuart L.
    Carr, Steven A.
    Ebert, Benjamin L.
    [J]. SCIENCE, 2014, 343 (6168) : 301 - 305
  • [17] The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
    Lu, Gang
    Middleton, Richard E.
    Sun, Huahang
    Naniong, MarkVic
    Ott, Christopher J.
    Mitsiades, Constantine S.
    Wong, Kwok-Kin
    Bradner, James E.
    Kaelin, William G., Jr.
    [J]. SCIENCE, 2014, 343 (6168) : 305 - 309
  • [18] PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition
    Mathur, Deepti
    Stratikopoulos, Elias
    Ozturk, Sait
    Steinbach, Nicole
    Pegno, Sarah
    Schoenfeld, Sarah
    Yong, Raymund
    Murty, Vundavalli V.
    Asara, John M.
    Cantley, Lewis C.
    Parsons, Ramon
    [J]. CANCER DISCOVERY, 2017, 7 (04) : 380 - 390
  • [19] Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes
    Menssen, A
    Hermeking, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6274 - 6279
  • [20] Pim kinases in hematological malignancies: where are we now and where are we going?
    Mondello, Patrizia
    Cuzzocrea, Salvatore
    Mian, Michael
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7